The Inability of Older Adults to Recall Their Drugs and Medical Conditions

Drugs and Aging

Volumn 32, Issue 4, 2015, Pages 329-336

  Jones, GaToya ^a   Tabassum, Vajeeha ^b   Zarow, Gregory J ^c   Ala, Thomas A ^a  

^a SOUTHERN ILLINOIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b East Tennessee State University   (United States)

^c The Emergency Statistician   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PRESCRIPTION DRUG;

AGED; FEMALE; HUMAN; MALE; NEUROPSYCHOLOGICAL TEST; RECALL; VERY ELDERLY;

AGED; AGED, 80 AND OVER; FEMALE; HUMANS; MALE; MENTAL RECALL; NEUROPSYCHOLOGICAL TESTS; PRESCRIPTION DRUGS;

EID: 84937759094     PISSN: 1170229X     EISSN: 11791969     Source Type: Journal    
DOI: 10.1007/s40266-015-0255-z     Document Type: Article

References (31)

1. Boparai MK, Korc-Grodzicki B. Prescribing for older adults. Mt Sinai J Med. 2011;78:613–26.
2. Steinman MA, Hanlon JT. Managing medications in clinically complex elders: “There’s got to be a happy medium”. JAMA. 2010;304:1592–601.
3. Wynne HA, Blagburn J. Drug treatment in an ageing population: practical implications. Maturitas. 2010;66:246–50.
4. Arlt S, Lindner R, Rosler A, et al. Adherence to medication in patients with dementia: predictors and strategies for improvement. Drugs Aging. 2008;25:1033–47.
5. Sela-Katz P, Rabinowitz I, Shugaev I, et al. Basic knowledge of the medication regimen correlates with performance on cognitive function tests and diagnosis of dementia in elderly patients referred to a geriatric assessment unit. Gerontology. 2010;56:491–5.
6. Conn VS, Taylor SG, Kelley S. Medication regimen complexity and adherence among older adults. Image J Nurs Sch. 1991;23:231–5.
7. Col N, Fanale J, Kronholm P. The role of medication noncompliance and adverse drug reactions in hospitalizations of the elderly. Arch Intern Med. 1990;150:841–5.
8. Barat I, Andreasen F, Damsgaard EM. Drug therapy in the elderly: what doctors believe and patients actually do. Br J Clin Pharmacol. 2001;51:615–22.
9. Lau S, Beuning KS, Postma-Lim E, et al. Non-compliance in elderly people: evaluation of risk factors by longitudinal data analysis. Pharm World Sci. 1996;18:63–8.
10. Centers for Medicare and Medicaid Services. EHR incentive programs. 2014 definition stage 1 of meaningful use. Available at: http://www.cms.gov/Regulations-and-Guidance/Legislation/EHRIncentivePrograms/Meaningful_Use.html. Accessed 18 Feb 2015.
11. Centers for Medicare and Medicaid Services. Stage 2. Eligible professional meaningful use core measures. Measure 14 of 17. Oct 2012. Available at: http://www.cms.gov/Regulations-and-Guidance/Legislation/EHRIncentivePrograms/downloads/Stage2_EPCore_14_MedicationReconciliation.pdf. Accessed 18 Feb 2015.
12. Folstein MF, Folstein SE, McHugh PR. “Mini-mental state”. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12:189–98.
13. Boustani M, Peterson B, Hanson L, et al. Screening for dementia in primary care: a summary of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med. 2003;138:927–37.
14. Tabachnick BG, Fidell LS. Using multivariate statistics. 5th ed. Boston: Allyn and Bacon; 2007.
15. al Mahdy H, Seymour DG. How much can elderly patients tell us about their medications? Postgrad Med J. 1990;66:116–21.
16. Rovner BW, Folstein MF. Mini-mental state exam in clinical practice. Hosp Pract. 1987;22:99–110.
17. Tangalos EG, Smith GE, Ivnik RJ, et al. The Mini-Mental State Examination in general medical practice: clinical utility and acceptance. Mayo Clin Proc. 1996;71:829–37.
18. Qato DM, Alexander GC, Conti RM, et al. Use of prescription and over-the-counter medications and dietary supplements among older adults in the United States. JAMA. 2008;300:2867–78.
19. Bushardt RL, Massey EB, Simpson TW, et al. Polypharmacy: misleading, but manageable. Clin Interv Aging. 2008;3:383–9.
20. Pasina L, Brucato AL, Falcone C, et al. Medication non-adherence among elderly patients newly discharged and receiving polypharmacy. Drugs Aging. 2014;31:283–9.
21. Blenkiron P. The elderly and their medication: understanding and compliance in a family practice. Postgrad Med J. 1996;72:671–6.
22. Congressional Record. The Patient Protection and Affordable Care Act (Sec. 4103) 2010. Available at: http://www.gpo.gov/fdsys/pkg/PLAW-111publ148/pdf/PLAW-111publ148.pdf. Accessed 18 Feb 2015.
23. Cordell CB, Borson S, Boustani M, et al. Alzheimer’s Association recommendations for operationalizing the detection of cognitive impairment during the Medicare Annual Wellness Visit in a primary care setting. Alzheimers Dement. 2013;9:141–50.
24. Brodaty H, Pond D, Kemp NM, et al. The GPCOG: a new screening test for dementia designed for general practice. J Am Geriatr Soc. 2002;50:530–4.
25. Borson S, Scanlan J, Brush M, et al. The mini-cog: a cognitive ‘vital signs’ measure for dementia screening in multi-lingual elderly. Int J Geriatr Psychiatry. 2000;15:1021–7.
26. Buschke H, Kuslansky G, Katz M, et al. Screening for dementia with the memory impairment screen. Neurology. 1999;52:231–8.
27. Moyer VA, U.S. Preventative Services Task Force. Screening for cognitive impairment in older adults: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2014;160:791–7.
28. Bedell SE, Jabbour S, Goldberg R, et al. Discrepancies in the use of medications: their extent and predictors in an outpatient practice. Arch Intern Med. 2000;160:2129–34.
29. Bikowski RM, Ripsin CM, Lorraine VL. Physician-patient congruence regarding medication regimens. J Am Geriatr Soc. 2001;49:1353–7.
30. Yang JC, Tomlinson G, Naglie G. Medication lists for elderly patients: clinic-derived versus in-home inspection and interview. J Gen Intern Med. 2001;16:112–5.
31. Somers SA, Mahadevan R. Health literacy implications of the Affordable Care Act. Center for Health Care Strategies, Inc., 2010. Available at: http://www.iom.edu/~/media/Files/Activity%20Files/PublicHealth/HealthLiteracy/2010-NOV-10/IOM%20health%20literacy%20paper%20FINAL_112910.pdf. Accessed 18 Feb 2015.